Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 00:02:45 GMT 2025
by
admin
on
Wed Apr 02 00:02:45 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG4 |
| Sequence Origin | MOUSE CHIMERIC |
| Sequence Type | COMPLETE |
| Record UNII |
23IQ3PO968
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
650418
Created by
admin on Wed Apr 02 00:02:45 GMT 2025 , Edited by admin on Wed Apr 02 00:02:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11865
Created by
admin on Wed Apr 02 00:02:45 GMT 2025 , Edited by admin on Wed Apr 02 00:02:45 GMT 2025
|
PRIMARY | |||
|
300000027016
Created by
admin on Wed Apr 02 00:02:45 GMT 2025 , Edited by admin on Wed Apr 02 00:02:45 GMT 2025
|
PRIMARY | |||
|
C172657
Created by
admin on Wed Apr 02 00:02:45 GMT 2025 , Edited by admin on Wed Apr 02 00:02:45 GMT 2025
|
PRIMARY | |||
|
2417175-94-9
Created by
admin on Wed Apr 02 00:02:45 GMT 2025 , Edited by admin on Wed Apr 02 00:02:45 GMT 2025
|
PRIMARY | |||
|
23IQ3PO968
Created by
admin on Wed Apr 02 00:02:45 GMT 2025 , Edited by admin on Wed Apr 02 00:02:45 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 2_22 | 2_96 |
| 2_129 | 4_218 |
| 2_142 | 2_198 |
| 2_256 | 2_316 |
| 1_129 | 3_218 |
| 2_362 | 2_420 |
| 3_23 | 3_92 |
| 3_138 | 3_198 |
| 4_23 | 4_92 |
| 4_138 | 4_198 |
| 1_142 | 1_198 |
| 1_221 | 2_221 |
| 1_224 | 2_224 |
| 1_256 | 1_316 |
| 1_362 | 1_420 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_292 |
| N | 2_292 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID REMOVAL | [1_442] [2_442] | C-TERMINUS | LYSINE | K3Z4F929H6 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|